Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease

INTRODUCTION: There are no empiric data to support guidelines for duration of therapy with antidementia drugs. This study examined whether persistent use of antidementia drugs slows clinical progression of Alzheimer disease (AD) assessed by repeated measures on serial tests of cognition and function...

Descripción completa

Detalles Bibliográficos
Autores principales: Rountree, Susan D, Chan, Wenyaw, Pavlik, Valory N, Darby, Eveleen J, Siddiqui, Samina, Doody, Rachelle S
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874259/
https://www.ncbi.nlm.nih.gov/pubmed/19845950
http://dx.doi.org/10.1186/alzrt7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874259/
https://www.ncbi.nlm.nih.gov/pubmed/19845950
http://dx.doi.org/10.1186/alzrt7

Ejemplares similares